Screening and Immunisation: Late jab is less useful

11 Mar 2021 - Screening

Vaccinating people over the age of 26 against a sexually transmitted virus that causes cancers might not be worth it, researchers say. Researchers used two mathematical models that simulated HPV infection and cervical cancer, as well as six non-cervical HPV-related cancers and genital warts, to determine long-term health outcomes for vaccinated and unvaccinated older adults. The findings from both models suggest HPV vaccination after 26 has limited health benefits and isn’t cost effective.

Courier Mail; 11/03/2021; Page 21